Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2020-000732-22Phase 4Active
Phase 4, randomised trial of levobupivacaine in cholelithiasis (2 arms), sponsored by Pablo Rama Maceiras. Primary endpoint: Total morphine dose in first 4 postoperative hours. Started May 2020; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2020-000732-22.